GSGurtej Singh

Gurtej Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gurtej Singh has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimizing the timing of autologous skin cell suspension after enzymatic debridement of porcine burns: Evaluation with digital image speckle correlation

    byĀ Shi Fu, Rachel Bonn, Huiting Luo, Robert Ruzic, Zachery Harris, Erica Heller, Steve McClain, Eugene Jiang, Briman Yang, Miriam Rafailovich, et al.

  • Structural analysis of a collagen-fibrin scaffold which promotes osteogenic differentiation and templated biomineralization of dental pulp stem cells

    byĀ Huiting Luo, Shi Fu, Muyun Cui, Kuan-Che Feng, Robert Wong, Adam Hansen, Tatiana Zaliznyak, David Sprouster, Olga Kleinerman, Gurtej Singh, et al.

  • Open Access

    Erase the trace: new frontiers in scar prevention and skin repair

    byĀ Shi Fu, Niharika Singh, Shiffoni Sukhlal, Huiting Luo, Divleen K. Singh, Mimi R Borrelli, Duc Bui, Sami Khan, Alexander B. Dagum, Gurtej Singh

    The management of scarring continues to be significant in health care due to their ubiquity and impact on daily life. Scars include immature, mature, atrophic, hypertrophic, and keloid scars, with hyp...

  • Open Access

    Autologous Skin Grafts, versus Tissue-engineered Skin Constructs: A Systematic Review and Meta-analysis

    byĀ Sara Mtm Kianian, Kelley Bs Zhao, Jasleen Bs Kaur, Kimberly W. Bs Lu, Sourish Bs Rathi, Kanad Md Ghosh, Hunter Bs Rogoff, Thomas R. Md Hays, Jason Park, Miriam Rafailovich, et al.

    Background: For over 100 years, autologous skin grafts have remained the gold standard for the reconstruction of wounds but are limited in availability. Acellular tissue-engineered skin constructs (acellular TCs) and cellular tissue-engineered skin constructs (cellular TCs) may address these limitations. This systematic review and meta-analysis compare outcomes between them. Methods: A systematic review was conducted using PRISMA guidelines, querying MEDLINE, Embase, Web of Science, and Cochrane to assess graft incorporation, failure, and wound healing. Case reports/series, reviews, in vitro/in vivo work, non-English articles or articles without full text were excluded. Results: Sixty-six articles encompassing 4076 patients were included. No significant differences were found between graft failure rates (P = 0.07) and mean difference of percent reepithelialization (p = 0.92) when split-thickness skin grafts were applied alone versus co-grafted with acellular TCs. Similar mean Vancouver Scar Scale was found for these two groups (p = 0.09). Twenty-one studies used at least one cellular TC. Weighted averages from pooled results did not reveal statistically significant differences in mean reepithelialization or failure rates for epidermal cellular TCs compared with split-thickness skin grafts (p = 0.55). Conclusions: This systematic review is the first to illustrate comparable functional and wound healing outcomes between split-thickness skin grafts alone and those co-grafted with acellular TCs. The use of cellular TCs seems promising from preliminary findings. However, these results are limited in clinical applicability due to the heterogeneity of study data, and further level 1 evidence is required to determine the safety and efficacy of these constructs.


  • Open Access

    Classification of Soft Tissue Sarcoma Specimens with Raman Spectroscopy as Smart Sensing Technology

    byĀ Liming Li, Vamiq M. Mustahsan, Guangyu He, Felix B. Tavernier, Gurtej Singh, Brendan F. Boyce, Fazel Khan, Imin Kao

    Intraoperative confirmation of negative resection margins is an essential component of soft tissue sarcoma surgery. Frozen section examination of samples from the resection bed after excision of sarcomas is the gold standard for intraoperative assessment of margin status. However, it takes time to complete histologic examination of these samples, and the technique does not provide real-time diagnosis in the operating room (OR), which delays completion of the operation. This paper presents a study and development of sensing technology using Raman spectroscopy that could be used for detection and classification of the tumor after resection with negative sarcoma margins in real time. We acquired Raman spectra from samples of sarcoma and surrounding benign muscle, fat, and dermis during surgery and developed (i) a quantitative method (QM) and (ii) a machine learning method (MLM) to assess the spectral patterns and determine if they could accurately identify these tissue types when compared to findings in adjacent H&E-stained frozen sections. High classification accuracy (>85%) was achieved with both methods, indicating that these four types of tissue can be identified using the analytical methodology. A hand-held Raman probe could be employed to further develop the methodology to obtain spectra in the OR to provide real-time in vivo capability for the assessment of sarcoma resection margin status.


  • Engineering functional skin constructs: A quantitative comparison of three‐dimensional bioprinting with traditional methods

    byĀ Juyi Li, Shi Fu, Kimberly W. Lu, Olias Christie, Michael T. Gozelski, Michael C. Cottone, Philip Cottone, Sara Kianian, Kuan‐Che Feng, Marcia Simon, et al.

    Tissue engineering has been successful in reproducing human skin equivalents while incorporating new approaches such as three‐dimensional (3D) bioprinting. The latter method offers a plethora of advantages including increased production scale, ability to incorporate multiple cell types and printing on demand. However, the quality of printed skin equivalents compared to those developed manually has never been assessed. To leverage the benefits of this method, it is imperative that 3D‐printed skin should be structurally and functionally similar to real human skin. Here, we developed four bilayered human skin epidermal‐dermal equivalents: non‐printed dermis and epidermis (NN), printed dermis and epidermis (PP), printed epidermis and non‐printed dermis (PN), and non‐printed epidermis and printed dermis (NP). The effects of printing induced shear stress [0.025 kPa (epidermis); 0.049 kPa (dermis)] were characterized both at the cellular and at the tissue level. At cellular level, no statistically significant differences in keratinocyte colony‐forming efficiency (CFE) (p = 0.1641) were observed. In the case of fibroblasts, no significant differences in the cell alignment index (p < 0.1717) and their ability to contract collagen gel (p = 0.851) were detected. At the tissue levels, all the four skin equivalents were characterized using histological and immunohistochemical analysis with no significant differences found in either epidermal basal cell count, thickness of viable epidermis, and relative intensity of filaggrin and claudin‐1. Our results demonstrated that 3D printing can achieve the same high‐quality skin constructs as have been developed traditionally, thus opening new avenues for numerous high‐throughput industrial and clinical applications.


  • Open Access

    Acellular Dermal Matrix Sterility: Does It Affect Microbial and Clinical Outcomes Following Implantation?

    byĀ Gabriel M. Klein, Gurtej Singh, Jocellie Marquez, Matthew Gebre, Robert Barry, Tara L. Huston, Jason C. Ganz, Sami U. Khan, Alexander B. Dagum, Duc T. Bui

    Introduction: The use of acellular dermal matrices (ADMs) in breast reconstruction is a controversial topic. Recent literature has investigated the effects of ADM sterilization on infectious complications, although with varying conclusions. Previous work by our group showed no difference between aseptic and sterilized products immediately out of the package. In this study, we investigate the microbiologic profiles of these agents after implantation. Methods: In this prospective study, we cultured samples of ADM previously implanted during the first stage of tissue expander-based immediate breast reconstruction. A 1 cm2 sample was excised during the stage II expander–implant exchange procedure, and samples were incubated for 48 hours in tryptic soy broth. Samples with growth were further cultured on tryptic soy broth and blood agar plates. Patient records were also analyzed, to determine if ADM sterilization and microbial growth were correlated with infectious complications. Results: In total, 51 samples of ADM were collected from 32 patients. Six samples were from aseptic ADM (AlloDerm), 27 samples were from ADM sterilized to 10–3 (AlloDerm Ready-to-Use), and 18 samples were from products sterilized to 10–6 (AlloMax). No samples demonstrated bacterial growth. Only 5 patients experienced postoperative complications, of whom only 1 patient was infectious in nature. We failed to demonstrate a statistically significant correlation between sterility and postoperative complications. Conclusions: Our findings showed no difference in microbial presence and clinical outcomes when comparing ADM sterility. Furthermore, no samples demonstrated growth in culture. Our study brings into question the necessity for terminal sterilization in these products.


  • Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents

    byĀ Manijeh Goldberg, Aaron Manzi, Erkin Aydin, Gurtej Singh, Payam Khoshkenar, Amritpreet Birdi, Brandon LaPorte, Alejandro Krauskopf, Geralle Powell, Julie Chen, et al.

    The following work describes the development of a novel noninvasive transmucosal drug delivery system, the chitosan sponge matrix (CSM). It is composed of cationic chitosan (CS) nanoparticles (NPs) that encapsulate cisplatin (CDDP) embedded within a polymeric mucoadhesive CS matrix. CSM is designed to swell up when exposed to moisture, facilitating release of the NPs via diffusion across the matrix. CSM is intended to be administered topically and locally to mucosal tissues, with its initial indication being oral cancer (OC). Currently, intravenous (IV) administered CDDP is the gold standard chemotherapeutic agent used in the treatment of OC. However, its clinical use has been limited by its renal and hemotoxicity profile. We aim to locally administer CDDP via encapsulation in CS NPs and deliver them directly to the oral cavity with CSM. It is hypothesized that such a delivery device will greatly reduce any systemic toxicity and increase antitumor efficacy. This paper describes the methods for developing CSM and maintaining the integrity of CDDP NPs embedded in the CSM.


  • Top Cited Papers

    Design and Fabrication of Human Skin by Three-Dimensional Bioprinting

    byĀ Vivian Lee, Gurtej Singh, John P. Trasatti, Chris Bjornsson, Xiawei Xu, Thanh Nga Tran, Seung-Schik Yoo, Guohao Dai, Pankaj Karande

    Three-dimensional (3D) bioprinting, a flexible automated on-demand platform for the free-form fabrication of complex living architectures, is a novel approach for the design and engineering of human organs and tissues. Here, we demonstrate the potential of 3D bioprinting for tissue engineering using human skin as a prototypical example. Keratinocytes and fibroblasts were used as constituent cells to represent the epidermis and dermis, and collagen was used to represent the dermal matrix of the skin. Preliminary studies were conducted to optimize printing parameters for maximum cell viability as well as for the optimization of cell densities in the epidermis and dermis to mimic physiologically relevant attributes of human skin. Printed 3D constructs were cultured in submerged media conditions followed by exposure of the epidermal layer to the air-liquid interface to promote maturation and stratification. Histology and immunofluorescence characterization demonstrated that 3D printed skin tissue was morphologically and biologically representative of in vivo human skin tissue. In comparison with traditional methods for skin engineering, 3D bioprinting offers several advantages in terms of shape- and form retention, flexibility, reproducibility, and high culture throughput. It has a broad range of applications in transdermal and topical formulation discovery, dermal toxicity studies, and in designing autologous grafts for wound healing. The proof-of-concept studies presented here can be further extended for enhancing the complexity of the skin model via the incorporation of secondary and adnexal structures or the inclusion of diseased cells to serve as a model for studying the pathophysiology of skin diseases.